Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

OBJECTIVE: The development of sufficient COVID-19 vaccines has been a big breakthrough in fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be reduced in patients with autoimmune rheumatic diseases (AIRD). The aim of this study was to identify factors that lead to a dim...

Descripción completa

Detalles Bibliográficos
Autores principales: Frommert, Leonie Maria, Arumahandi de Silva, Amanthi Nadira, Zernicke, Jan, Scholz, Veronika, Braun, Tanja, Jeworowski, Lara Maria, Schwarz, Tatjana, Tober-Lau, Pinkus, ten Hagen, Alexander, Habermann, Elisa, Kurth, Florian, Sander, Leif Erik, Corman, Victor Max, Burmester, Gerd-Rüdiger, Biesen, Robert, Albach, Fredrik N., Klotsche, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729845/
https://www.ncbi.nlm.nih.gov/pubmed/36597977
http://dx.doi.org/10.1136/rmdopen-2022-002650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729845/
https://www.ncbi.nlm.nih.gov/pubmed/36597977
http://dx.doi.org/10.1136/rmdopen-2022-002650

Ejemplares similares